175 related articles for article (PubMed ID: 10704956)
1. IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans.
D'Souza DC; Gil R; Cassello K; Morrissey K; Abi-Saab D; White J; Sturwold R; Bennett A; Karper LP; Zuzarte E; Charney DS; Krystal JH
Biol Psychiatry; 2000 Mar; 47(5):450-62. PubMed ID: 10704956
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence.
Krystal JH; Petrakis IL; Limoncelli D; Nappi SK; Trevisan L; Pittman B; D'Souza DC; Suckow RF
Neuropsychopharmacology; 2011 Feb; 36(3):701-10. PubMed ID: 21124304
[TBL] [Abstract][Full Text] [Related]
3. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
[TBL] [Abstract][Full Text] [Related]
4. Effects of D-cycloserine on negative symptoms in schizophrenia.
Duncan EJ; Szilagyi S; Schwartz MP; Bugarski-Kirola D; Kunzova A; Negi S; Stephanides M; Efferen TR; Angrist B; Peselow E; Corwin J; Gonzenbach S; Rotrosen JP
Schizophr Res; 2004 Dec; 71(2-3):239-48. PubMed ID: 15474895
[TBL] [Abstract][Full Text] [Related]
5. Glycine and D: -serine, but not D: -cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801.
Kanahara N; Shimizu E; Ohgake S; Fujita Y; Kohno M; Hashimoto T; Matsuzawa D; Shirayama Y; Hashimoto K; Iyo M
Psychopharmacology (Berl); 2008 Jun; 198(3):363-74. PubMed ID: 18437299
[TBL] [Abstract][Full Text] [Related]
6. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.
Goff DC; Tsai G; Levitt J; Amico E; Manoach D; Schoenfeld DA; Hayden DL; McCarley R; Coyle JT
Arch Gen Psychiatry; 1999 Jan; 56(1):21-7. PubMed ID: 9892252
[TBL] [Abstract][Full Text] [Related]
7. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
[TBL] [Abstract][Full Text] [Related]
8. Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment.
Tsai GE; Falk WE; Gunther J; Coyle JT
Am J Psychiatry; 1999 Mar; 156(3):467-9. PubMed ID: 10080566
[TBL] [Abstract][Full Text] [Related]
9. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.
Buchanan RW; Javitt DC; Marder SR; Schooler NR; Gold JM; McMahon RP; Heresco-Levy U; Carpenter WT
Am J Psychiatry; 2007 Oct; 164(10):1593-602. PubMed ID: 17898352
[TBL] [Abstract][Full Text] [Related]
10. Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo.
Emmett MR; Mick SJ; Cler JA; Rao TS; Iyengar S; Wood PL
Neuropharmacology; 1991 Nov; 30(11):1167-71. PubMed ID: 1663594
[TBL] [Abstract][Full Text] [Related]
11. Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test.
Anthony EW; Nevins ME
Eur J Pharmacol; 1993 Dec; 250(2):317-24. PubMed ID: 7906654
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis.
Heresco-Levy U; Javitt DC
Schizophr Res; 2004 Feb; 66(2-3):89-96. PubMed ID: 15061240
[TBL] [Abstract][Full Text] [Related]
13. Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management.
Fone KCF; Watson DJG; Billiras RI; Sicard DI; Dekeyne A; Rivet JM; Gobert A; Millan MJ
Mol Neurobiol; 2020 May; 57(5):2144-2166. PubMed ID: 31960362
[TBL] [Abstract][Full Text] [Related]
14. Alterations in plasma and brain amino acids after administration of the glycine/NMDA receptor partial agonist, D-cycloserine, to mice and rats.
Baran H; Gramer M; Löscher W
Eur J Pharmacol; 1995 Jan; 273(1-2):197-201. PubMed ID: 7737315
[TBL] [Abstract][Full Text] [Related]
15. D-cycloserine added to clozapine for patients with schizophrenia.
Goff DC; Tsai G; Manoach DS; Flood J; Darby DG; Coyle JT
Am J Psychiatry; 1996 Dec; 153(12):1628-30. PubMed ID: 8942463
[TBL] [Abstract][Full Text] [Related]
16. D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys.
Matsuoka N; Aigner TG
J Pharmacol Exp Ther; 1996 Aug; 278(2):891-7. PubMed ID: 8768744
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and neuroendocrine effects of the partial NMDA agonist D-cycloserine in healthy subjects.
van Berckel BN; Lipsch C; Timp S; Gispen-de Wied C; Wynne H; van Ree JM; Kahn RS
Neuropsychopharmacology; 1997 May; 16(5):317-24. PubMed ID: 9109102
[TBL] [Abstract][Full Text] [Related]
18. The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers.
van Berckel BN; Lipsch C; Gispen-de Wied C; Wynne HJ; Blankenstein MA; van Ree JM; Kahn RS
Psychopharmacology (Berl); 1998 Jul; 138(2):190-7. PubMed ID: 9718289
[TBL] [Abstract][Full Text] [Related]
19. Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice.
Wlaź P; Baran H; Löscher W
Eur J Pharmacol; 1994 May; 257(3):217-25. PubMed ID: 8088343
[TBL] [Abstract][Full Text] [Related]
20. Effect of the NMDA receptor partial agonist, d-cycloserine, on emotional processing and autobiographical memory.
Chen R; Capitão LP; Cowen PJ; Harmer CJ
Psychol Med; 2021 Nov; 51(15):2657-2665. PubMed ID: 32375905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
